FDA Class II Recall: DeRoyal BIOPSY PACK Medical Device
DeRoyal Industries has recalled 480 units of its BIOPSY PACK (REF 89-9614.07) in a voluntary, firm-initiated recall affecting 23 US states. The specific reason for the recall has not been disclosed.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device recall for a product used in invasive surgical procedures (biopsies), which inherently carry risk of potential harm. No illnesses or injuries have been reported. The classification meets the rubric criterion for high severity: risk-of-harm products where injury has not yet been reported.
Plain-English summary
DeRoyal Industries Inc has recalled 480 units of the DeRoyal BIOPSY PACK (REF 89-9614.07), an FDA Class II medical device. The affected product was distributed across 23 US states: Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, and Mississippi.
The recall was initiated voluntarily by DeRoyal Industries Inc on November 3, 2022, with FDA classification on December 15, 2022. The specific reason for the recall has not been provided in the agency documentation. The affected lot numbers are: Lot 56584885 (expiration 9/1/2024), Lot 57030745 (expiration 2/1/2025), and Lot 57686461 (expiration 5/1/2025).
Healthcare facilities and individuals who have received or are using this product should contact DeRoyal Industries Inc for recall instructions and guidance. The company has notified customers through email, fax, letter, press release, telephone, and on-site visits.
The recalled product
- Product
- DeRoyal BIOPSY PACK, REF 89-9614.07
- Manufacturer
- DeRoyal Industries Inc
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot Numbers: Lot 56584885 exp 9/1/2024
- Lot 57030745 exp 2/1/2025
- Lot 57686461 exp 5/1/2025
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Trays Recalled Due to Quality and Efficacy Concerns
FDA (Devices) · 2026-06-03
- HighMedline Medical Convenience Kit Recalled: Wrong Syringe Type Inside
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03